Literature DB >> 14561161

Cytokine network in inflammatory bowel disease.

Ivan J Fuss1.   

Abstract

Disease states, such as those characterized by inflammation of the gastrointestinal tract (Crohn's disease and ulcerative colitis), are due to a host of factors that act in concert to produce pathologic change. The immunologic factors that mediate the development of such mucosal inflammation have been at the forefront of IBD research. Recently, a better understanding of the mechanisms involved in mucosal homeostasis and the occurrence of inflammatory bowel disease (IBD) has been achieved with the advent of animal models of mucosal inflammation. This review discusses these models and the insights they provide into the pathogenesis and regulation of IBD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561161     DOI: 10.2174/1568010033484197

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  6 in total

1.  Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer.

Authors:  Aleksandra M Urbanska; Emmanouil D Karagiannis; Gonzalo Guajardo; Robert S Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

2.  Stress granule formation mediates the inhibition of colonic Hsp70 translation by interferon-gamma and tumor necrosis factor-alpha.

Authors:  Shien Hu; Erika C Claud; Mark W Musch; Eugene B Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-28       Impact factor: 4.052

3.  Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

Authors:  Sofia Tedelind; Fredrik Westberg; Martin Kjerrulf; Alexander Vidal
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

4.  Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammation.

Authors:  Shien Hu; Mae J Ciancio; Maor Lahav; Mikihiro Fujiya; Lev Lichtenstein; Shrikant Anant; Mark W Musch; Eugene B Chang
Journal:  Gastroenterology       Date:  2007-09-25       Impact factor: 22.682

5.  Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis.

Authors:  Jun-Hua Li; Jie-Ping Yu; Hong-Gang Yu; Xi-Ming Xu; Liang-Liang Yu; Jin Liu; He-Sheng Luo
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

Review 6.  Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.

Authors:  Andrea Brioschi; Gian Paolo Zara; Sara Calderoni; Maria Rosa Gasco; Alessandro Mauro
Journal:  Molecules       Date:  2008-02-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.